Status:
ACTIVE_NOT_RECRUITING
Psychosocial Mobile Application (THRIVE-M) for Patients With Multiple Myeloma
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial aims to evaluate whether a psychosocial mobile application (THRIVE-M), is efficacious for improving quality of life, psychological distress, and fatigue in patients living with mul...
Detailed Description
Multiple myeloma, the second most common hematologic malignancy, can be associated with severe end-organ destruction and life-threatening complications (e.g., kidney failure, infection, anemia) result...
Eligibility Criteria
Inclusion
- Adult patients (aged 18 years or older) with one of the following diagnoses:
- newly diagnosed multiple myeloma receiving first-line therapy,
- multiple myeloma on maintenance therapy, or
- relapsed multiple myeloma receiving 2nd or 3rd line therapy
- Ability to comprehend, read, and respond to questions in English
Exclusion
- \- Patients with acute or unstable psychiatric or cognitive conditions that the treating clinicians believe prohibit informed consent or compliance with study procedures
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06073353
Start Date
December 1 2023
End Date
March 31 2026
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02115